Drugs / lopinavir/ritonavir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00884793 | Sep 2008 → Dec 2009 | HIV infectious disease | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lopinavir/ritonavir | “PIs used as study drugs will include atazanavir (+/- ritonavir), fosamprenavir (+/-ritonavir), lopinavir/ritonavir, and darunavir/ritonavir.” NCT00884793 ↗ |
| Known as | lopinavir/ritonavir (Kaletra, LPV/r) | “lopinavir/ritonavir (Kaletra, LPV/r)” NCT00884793 ↗ |